Stock NKTX NKARTA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Nkarta, Inc.

Equities

NKTX

US65487U1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
6.51 USD +0.70% Intraday chart for Nkarta, Inc. +25.68% -1.36%
Jun. 27 Nkarta Initiates Trial of Cell Therapy to Treat Lupus Nephritis; FDA Clears Second Application MT
Jun. 27 Nkarta, Inc. Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. NKTX Stock
  4. Revisions Nkarta, Inc.